The drug regulator subsequently ordered companies to take the medicine off the market. Since then, Sanofi (SNY) has brought Zantac back to the market, but without ranitidine. It is now made with ...
GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it ...